Clinical Trial Update: Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating mesenchymal stem cell therapy for diabetic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED